The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of itraconazole in biochemically recurrent prostate cancer.
 
Mina Lee
No Relationships to Disclose
 
Haemin Hong
No Relationships to Disclose
 
Won Kim
Consulting or Advisory Role - Bayer; Dendreon; Genentech/Roche
 
Terence W. Friedlander
Leadership - Med BioGene
Honoraria - EMD Serono
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Genentech; Pfizer
Speakers' Bureau - Astellas Medivation; Dendreon; Sanofi
Research Funding - Aragon Pharmaceuticals (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Janssen
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Clovis Oncology; Genentech/Roche
 
Lawrence Fong
Consulting or Advisory Role - Atreca; IDEAYA Biosciences; MIODx
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Nektar (Inst); Roche/Genentech (Inst)
 
Amy M. Lin
No Relationships to Disclose
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics
Honoraria - Janssen-Cilag
Consulting or Advisory Role - Fortis; Gilead Sciences; Valeant Pharmaceuticals International
Research Funding - Janssen (Inst)
 
Mallika Sachdev Dhawan
No Relationships to Disclose
 
Xiao X. Wei
No Relationships to Disclose
 
Tammy J. Rodvelt
No Relationships to Disclose
 
Brigid Miralda
No Relationships to Disclose
 
Charles J. Ryan
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - Bayer; Millennium
Research Funding - BIND Biosciences; Karyopharm Therapeutics; Novartis
 
Rahul Raj Aggarwal
Research Funding - Gilead Sciences; Novartis; Sanofi; Zenith Epigenetics